U.S. Medical Equipment Stock News

Investors may be wondering whether Portland General Electric at around US$49.29 is offering good value right now, or if the recent gains have already been priced in. The stock is up 1.8% over the last week, has fallen 6.0% over the last month, and sits on a 20.5% return over the past year, which may signal shifting expectations around both its potential and its risks. Recent coverage around Portland General Electric has focused on its role as a regulated electric utility and how it fits into...

Columbia Banking System, Inc. recently declared a quarterly cash dividend of US$0.37 per common share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. This latest payout extends the bank’s long record of regular cash distributions, underscoring its emphasis on shareholder returns even as it works through profitability challenges. With this confirmed US$0.37 quarterly dividend in place, we’ll now consider how the payout shapes Columbia Banking System’s broader...

Today is shaping up negative for Antalpha Platform Holding Company ( NASDAQ:ANTA ) shareholders, with the covering...

If you are wondering whether Marsh & McLennan Companies, at around US$166 per share, still offers solid value, it helps to step back and look at what the current price might be implying. The stock is up 1.6% over the last 7 days, but is down 5.5% over 30 days, down 9.0% year to date, and has fallen 26.7% over the past year, which may have shifted how the market is thinking about its risk and return profile. Recent attention on the broader insurance and risk management sector has kept Marsh &...

Inhibrx Biosciences (INBX) has become a focus for biotech investors after reporting interim Phase 2 HexAgon data on INBRX-106 combined with pembrolizumab in first-line head and neck cancer, alongside a recent first quarter earnings update. See our latest analysis for Inhibrx Biosciences. The interim HexAgon data and first quarter earnings update come after a period of strong market interest, with a 30 day share price return of 24.12% and a year to date share price return of 45.94%. The 1 year...

Waystar Holding's Board of Directors has authorized a $200 million stock repurchase plan. The buyback approval covers shares of NasdaqGS:WAY at a current share price of $19.6. The program signals an intention to return capital to shareholders through share repurchases. For investors watching NasdaqGS:WAY, the new $200 million buyback plan comes after a challenging period for the stock. The share price is $19.6, with the stock down 24.0% over the past 30 days, down 37.5% year to date, and...

Innospec (IOSP) has announced a new US$75 million share repurchase authorization along with a 10% increase in its semi-annual dividend, placing capital returns at the center of the current story for the stock. See our latest analysis for Innospec. The buyback and dividend increase come after a mixed period for Innospec, with the share price falling 11% over the past three months and the 1 year total shareholder return down 12%, suggesting sentiment has been cooling despite recent capital...

AMC Entertainment Holdings (NYSE:AMC) is planning a nationwide theatrical release of the comedy film "Bad Counselors" through its Fathom Entertainment division. The release is scheduled for July 2026 and focuses on specialty content distribution beyond traditional studio movies. The move highlights AMC's push to use Fathom Entertainment as a platform for alternative programming that sits alongside regular Hollywood titles. For investors tracking NYSE:AMC, this specialty release arrives...

Why Global Industrial’s Q1 Beat Matters for Investors Global Industrial (GIC) reported Q1 revenue 9.2% higher year over year, with adjusted operating income above analyst estimates. Despite this, the stock is down about 12% since the release and trades near $28.92. This combination of headline strength and softer profitability, driven by higher marketing, compensation, fuel surcharges, and tariffs, leaves investors weighing how much value to place on the current growth across core accounts...

Elliott Investment Management has built a significant stake in Bio-Rad Laboratories (NYSE:BIO). The activist position signals potential pressure for changes in operations, governance, or portfolio structure. This development comes as Bio-Rad’s shares trade at $281.05 and the company holds a sizable stake in Sartorius. For investors tracking NYSE:BIO, Elliott’s move lands on top of a mixed share price record, with the stock up 16.3% over the past week and 13.8% over the past year, but down...

Why New Horizon Aircraft’s latest equity raise matters for investors New Horizon Aircraft (NasdaqCM:HOVR) has just completed a registered direct follow on equity offering of about US$19.9 million, selling 9,254,889 Class A ordinary shares at US$2.15, a US$0.1505 discount per share. This capital raise, alongside recent calls outlining plans for its hybrid electric vertical takeoff and landing platform, puts fresh attention on how the company intends to fund development while managing dilution...

iRhythm Holdings recently reported its sixth consecutive quarter of over 20% growth, driven by its core Zio Monitor business, alongside improving profitability supported by automation and operating scale. The company also reaffirmed plans to launch its AI-enabled Zio MCT offering in the first half of 2027, underscoring its focus on efficiency and cost savings. We’ll now explore how iRhythm’s sustained growth and AI-enabled product roadmap may influence the company’s existing investment...

Earlier in May 2026, Alvotech reported that the FDA completed a routine cGMP surveillance inspection of its Reykjavik manufacturing facility, issuing a Form 483 that the company believes involves addressable observations and supports resubmission of key Biologics License Applications this quarter. Management is framing the inspection outcome as validation of the site’s quality improvements and as support for its expectation of FDA decisions on the relevant BLAs during 2026, a crucial pillar...

Patrick Industries (NasdaqGS:PATK) held its annual shareholder meeting, electing a new board of directors and ratifying its auditor. Shareholders approved the latest executive compensation package. The company reaffirmed its focus on shareholder returns with a newly declared dividend and recent share buybacks. Patrick Industries enters this period of corporate housekeeping with its stock at $88.79 and a mixed recent track record. The share price is down 5.9% over the past week, down 17.0%...

Resideo Technologies (REZI) has been drawing fresh attention after recent share price moves, with the stock down 27% over the past week and about 33% lower over the past month. See our latest analysis for Resideo Technologies. Zooming out, the recent share price drop sits alongside a weaker short term trend, with the stock down over the past quarter, while the 1 year total shareholder return remains positive and suggests earlier gains are being reassessed. If sharp moves in home and building...

Investors may be wondering if Digital Realty Trust at about US$186 per share still offers value, or if most of the upside has already been priced in. The stock is up 20.2% year to date and 12.7% over the past year, even though it has fallen 4.6% over the last week and 8.5% over the last month. These moves can change how investors think about its risk and reward trade off. Recent attention on data center operators tied to artificial intelligence, along with ongoing discussion around funding...

If you are wondering whether Graco's current share price lines up with its underlying value, this breakdown will help you connect the dots before you commit new capital. Graco's stock recently closed at US$75.32, with the share price down 2.3% over the past week, 13.2% over the last month and 12.0% over the past year, while edging up 1.6% over three years and 6.8% over five years. Recent coverage around Graco has focused on its position in the capital goods space and investor interest in how...

Royal Gold restructured its interest in the Hod Maden Project, exchanging its direct ownership stake for a 2.5% net smelter return royalty. The transaction involved selling part of its equity stake to project partner Lidya Mines while retaining exposure through future royalty payments. This move reduces Royal Gold's exposure to project capital and operating costs and increases its focus on royalty based income. Royal Gold, ticker NasdaqGS:RGLD, recently experienced mixed share price...

Exponent (EXPO) is back in focus after its latest quarter, where revenue grew 10.5% year on year and topped forecasts by 1.8%, while earnings per share fell short and raised questions about profitability. See our latest analysis for Exponent. Since that earnings release, the stock’s 30 day share price return is down 16.25% and the year to date share price return is down 18.76%, while the 1 year total shareholder return has declined 26.98%. This points to fading momentum as investors reassess...

Synaptics (SYNA) has attracted fresh attention after its Coralboard Edge AI platform, built with Google Research, featured at Google I/O 2026. This highlighted the company’s role in on-device AI and upcoming COMPUTEX Taipei presentations. See our latest analysis for Synaptics. Recent events around Coralboard at Google I/O and Synaptics’ COMPUTEX plans have coincided with a 54.13% 1 month share price return and a 90.22% 1 year total shareholder return, suggesting strong momentum built over...

Carl Icahn’s renewed bullish stance on CVR Partners (UAN), along with increased ownership and a quarterly cash distribution nearly 80% higher than a year earlier, is pulling fresh investor attention to the nitrogen fertilizer producer. See our latest analysis for CVR Partners. The share price tells a mixed story, with a 17.44% 90 day share price return and a 24.95% year to date share price return. At the same time, the 1 year total shareholder return of 71.76% and 5 year total shareholder...

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, yet it remains up by an impressive 23% over the past year, with earnings forecasted to grow by 17% annually. In such a fluctuating environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this context of overall market growth and temporary fluctuations, stocks with high insider ownership can offer valuable insights into potential long-term performance as insiders' confidence may align their interests with those of other shareholders.

Over the last 7 days, the U.S. market has dropped by 1.0%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential is crucial for investors seeking stability and opportunity. While "penny stocks" may sound like an outdated term, they continue to represent smaller or less-established companies that can offer significant value; we've identified three such stocks...